Skip to content
Review Open access

Mitochondrial damage and post-translational modifications in radiation-induced heart disease: mechanisms and emerging therapeutic targets

Aug 2026 · Frontiers in Pediatrics · Vol 14 · 0 citations · 74 references
Medicine

TL;DR

It is proposed that persistent disruption of mitochondrial homeostasis represents a central link between early radiation-induced injury and late cardiac remodeling and provides a potential biological explanation for the long latency and progressive nature of RIHD.

Abstract

Background Radiation-induced heart disease (RIHD) is a major late complication of thoracic radiotherapy. However, the mechanisms responsible for its long-term progression remain poorly understood. Conventional explanations, such as DNA damage, and oxidative stress, mainly focus on early radiation responses and fail to fully account for the prolonged latency and progressive myocardial remodeling observed in RIHD over years to decades. Main content This review proposes that persistent disruption of mitochondrial homeostasis represents a central link between early radiation-induced injury and late cardiac remodeling. We systematically summarize the major processes involved in radiation-induced mitochondrial dysfunction. These processes include mtDNA damage, respiratory chain impairment, sustained mitochondrial reactive oxygen species (mitoROS) accumulation, metabolic network remodeling, and defective mitochondrial clearance through mitophagy. We further discuss how acetylation, SUMOylation, and lactylation regulate these processes and contribute to the development and progression of RIHD. Building on this framework, we highlight emerging molecular targets, including NDP52, ATP5F1C, P4HB, and SH3GLB1, as well as the potential protective effects of bioactive compounds derived from traditional Chinese medicine, such as aloe-emodin and astragaloside IV, through restoration of mitochondrial homeostasis. By integrating mitochondrial dysfunction, post-translational modifications, and mitophagy into a unified pathological framework, this review provides new perspectives for early identification and therapeutic intervention in RIHD. Key conclusions RIHD is not simply an oxidative stress-driven disorder but rather a chronic remodeling process shaped by the interplay among mitochondrial injury, post-translational modifications, and mitophagy dysregulation. This integrated framework links early subcellular alterations to late cardiac remodeling and provides a potential biological explanation for the long latency and progressive nature of RIHD. However, most current evidence is derived from adult models. Future research should specifically address childhood cancer survivors, as radiation exposure during critical periods of cardiac development may result in distinct long-term cardiovascular outcomes.

Read PDF

Similar papers

Review Open access Aug 2026

Post-translational modifications in sepsis-induced myocardial dysfunction - Molecular mechanisms and therapeutic targets: A review.

Sepsis-induced myocardial dysfunction (SIMD) is a frequent and life-threatening complication of sepsis driven by interconnected inflammatory, oxidative, metabolic, and mitochondrial disturbances. Post-translational modifications (PTMs) have emerged as key regulators of these processes by dynamically altering protein activity, stability, localization, and signaling. This narrative review aimed to summarize the roles of major PTMs in SIMD and evaluate their potential as therapeutic targets. Relevant original studies and authoritative reviews published predominantly within the past decade were identified through targeted searches of PubMed and Web of Science and qualitatively synthesized. Current evidence indicates that phosphorylation, acetylation, ubiquitination, protein methylation, ADP-ribosylation, and palmitoylation regulate major pathways involved in myocardial inflammation, oxidative stress, mitochondrial dysfunction, metabolic reprogramming, apoptosis, and impaired contractility. Crosstalk among these modifications further integrates signaling networks, while upstream epigenetic mechanisms, including DNA methylation and N6-methyladenosine RNA modification, can influence PTM-related enzymes and downstream signaling. Experimental studies also suggest that pharmacological modulation of PTM-regulated pathways may attenuate myocardial injury; however, most mechanistic and therapeutic evidence derives from animal models and cultured cells, with limited validation in human septic myocardium. PTMs therefore represent promising mechanistic and therapeutic targets in SIMD, but systematic characterization of PTM crosstalk and rigorous human translational studies are required before PTM-directed strategies can be incorporated into clinical practice.

Xuan Liu, Hai-Hua Pan, Jun Cha et al. · 0 citations
Review Open access Aug 2026

Targeting Oxidative and Nitrosative Stress: Mechanistic Insights and Therapeutic Strategies for Radiation-Induced Lung Injury

Abstract Radiation-induced lung injury (RILI) remains a major complication of thoracic radiotherapy, limiting curative treatment for thoracic malignancies. Oxidative and nitrosative stress have emerged as central mechanisms driving the initiation and progression of RILI, orchestrating inflammatory signaling, immune dysregulation, and fibrotic remodeling. In this review, we first introduce the “pro-stress milieu” created by the pre-existing tumor microenvironment (TME) briefly. Then we provide a detailed mechanistic dissection of the molecular and cellular pathways through which ionizing radiation generates reactive oxygen and nitrogen species, including water radiolysis, mitochondrial dysfunction, enzyme activation (NOX, DUOX, COX-2, iNOS), and impairment of endogenous antioxidant defenses such as Nrf2 and SOD. We also highlight emerging mechanisms, such as tetrahydrobiopterin (BH4) depletion and NOS uncoupling, which broaden the current understanding of redox imbalance in RILI. Subsequently, we provide a comprehensive overview of therapeutic strategies targeting oxidative and nitrosative stress, spanning small-molecule drugs, natural metabolites, mesenchymal stem cells and exosomes, bioengineered nanomaterials, plant-derived extracts, and traditional medicines. Each modality is assessed for its mechanistic basis, efficacy in preclinical models, and, crucially, the challenges hindering clinical adoption. Finally, we discuss current limitations and future perspectives, including biomarker development, precision redox modulation, and combinatorial approaches, which may accelerate the translation of redox-targeted therapies into effective interventions for RILI.

Weiwen Zhao, Yue Ma, Ting Fang et al. · 0 citations
Review Open access Jul 2026

The central role of mitochondrial pathology in sepsis-induced cardiomyopathy: from molecular mechanisms to clinical translation

This review examines mitochondrial pathology as the central orchestrator of SIC progression and integrates mitochondrial biology, immunometabolism, and translational medicine to identify promising directions for improving patient outcomes.

Linghong Xu, Jun Zhang, Huijing Tong et al. · 0 citations
#gene editing Review Aug 2026

Mitochondrial Dysfunction as a Central Hub of Aging: From Molecular Cascades to Inter-Organ Communication Networks.

This review elucidates the core mechanisms underpinning this dysfunction, including reactive oxygen species (ROS)-induced redox imbalance, mitochondrial DNA (mtDNA) damage accumulation, impaired mitophagy, and metabolic reprogramming, and critically examines how mitochondria act as signaling hubs for inter-organ crosstalk.

Chao-Dong Han, Zilian Zhang, Yafeng Song · 0 citations
Review Open access Aug 2026

Mitochondrial quality control in acute liver injury and its therapeutic implications (Review)

Acute liver injury (ALI) is a clinically important syndrome with limited mechanism-based therapies. Notably, mitochondrial dysfunction is increasingly recognized as a central driver of hepatocellular damage and repair failure. The present narrative review aims to summarize the current evidence on mitochondrial quality control (MQC) in ALI, with an emphasis on mitophagy, mitochondrial biogenesis, mitochondrial dynamics, etiology-specific regulation and therapeutic implications. For the present review, relevant experimental and translational studies addressing MQC-related mechanisms and interventions in major forms of ALI, including drug-induced liver injury, ischemia-reperfusion injury and viral ALI, were reviewed and integrated. The findings indicated that MQC operates as an interconnected network rather than as isolated pathways. Mitophagy, mitochondrial dynamics and mitochondrial biogenesis are temporally coordinated to remove damaged mitochondria, remodel mitochondrial networks and restore bioenergetic capacity. However, MQC responses differ across ALI etiologies, and inappropriate or excessive activation may become maladaptive. In conclusion, understanding MQC as a dynamic and context-dependent repair system may provide a conceptual basis for precision interventions in ALI. Future studies should clarify spatiotemporal MQC regulation, establish reliable biomarkers and validate MQC-targeted therapies in clinically relevant settings.

Ziqiang Chen, Yunhe Wang, Yijing Li et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.